Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients-Reference-Cited by-同舟云学术

Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients

Published:2017-11-21 Issue:3 Volume:18 Page:501-505
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Oetting W S, ,Wu B,Schladt D P,Guan W,Remmel R P,Mannon R B,Matas A J,Israni A K,Jacobson P A

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201749.pdf

Reference43 articles.

1. Iwasaki K . Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet 2007; 22: 328–335.

2. Daly AK . Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 2006; 45: 13–31.

3. Kamden LK, Streit F, Zanger UM, Oellerich M, Armstrong VW, Wojnowski L . Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin Chem 2005; 51: 1374–1381.

4. Dai Y, Hebert MF, Isoherrannen N, Davis CL, Marsh C, Shen DD et al. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos 2006; 34: 836–847.

5. Li JL, Liu S, Fu Q, Zhang Y, Wang XD, Liu XM et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. Pharmacogenomics 2015; 16: 1355–1365.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extreme phenotype sampling and next generation sequencing to identify genetic variants associated with tacrolimus in African American kidney transplant recipients;The Pharmacogenomics Journal;2024-08-23

2. Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients;ACS Pharmacology & Translational Science;2024-08-13

3. Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes;British Journal of Clinical Pharmacology;2024-07-12

4. Toward Equitable Heart Transplant Outcomes;JACC: Heart Failure;2024-07

5. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation;Transplantation;2024-02-16